A new generation vaccine candidate developed at Cleveland Clinic protects against multiple influenza B strains and lasts longer than currently used vaccines.
Recent preclinical results show that a new generation vaccine candidate developed at Cleveland Clinic protects against multiple influenza B strains and lasts longer than currently used vaccines.The study, published in Scientific Reports, attributes the influenza B vaccine’s preclinical success to… + Read more
Clinical trials of new candidate for universal flu vaccine begin
Recruitment has begun for a Phase 1 trial of a new investigational universal influenza vaccine candidate targeting six strains of the virus. + read more
Women may be at higher risk of flu vaccine reactions
A recent study suggests that sex differences need to be considered in vaccination programs as a potential factor in vaccine safety assessment and recommendations. + read more
WHO recognizes no vaccine can protect everyone against avian influenza
A total of 873 human H5N1 cases have been recorded in 21 countries over the past 20 years, with 458 resulting in deaths, according to the United Nations health agency. + read more
New cases of H5N1 avian influenza in China
The World Health Organization reminds us that certain strains of highly pathogenic avian influenza have the ability to infect humans and pose a threat to public health. + read more
New influenza B vaccine protects against multiple influenza strains
A new generation vaccine candidate developed at Cleveland Clinic protects against multiple influenza B strains and lasts longer than currently used vaccines. + read more
Molecular tests to monitor the unpredictable spread of SARS-CoV-2 and influenza viruses
Using swabs, ID NOW™ provides flexible testing for COVID-19 and/or influenza (Influenza A and B), providing fast, accurate results in just minutes at the point of care. + read more